
A recent U.S. Court of Appeals ruling has underscored the critical importance of meticulous documentation in pharmacy practice, particularly concerning vaccine administration. The case, detailed by Jim Ruble, PharmD, JD, involved a patient’s lawsuit against a national chain pharmacy that was ultimately dismissed due to insufficient evidence—a consequence of incomplete records.
The lawsuit stemmed from a patient who, in December 2017, received two vaccinations simultaneously: a diphtheria-tetanus-pertussis booster (Tdap) and a pneumococcal polysaccharide vaccine. Both were administered so closely that they appeared to be a single injection site. Immediately after the first shot, the patient experienced significant pain. Over the next two days, the pain and inflammation in her shoulder worsened, leading to a diagnosis of complex regional pain syndrome.
The patient’s legal team filed a lawsuit in December 2020, alleging that the negligent administration of the pneumococcal vaccine was the cause of her “painful and permanent” nerve injuries. However, the case faced a critical hurdle: there was no documentation or witness recollection to establish which of the two vaccines was administered first.
The Legal Conundrum
The lack of this seemingly small detail had major legal implications due to the National Childhood Vaccine Injury Act (VIC). This 1986 federal law created a specific program for compensating individuals for injuries caused by certain vaccines, including the Tdap booster. Claims for these injuries must be made through the VIC program, which grants legal immunity to pharmacists and manufacturers from civil lawsuits. Crucially, the pneumococcal vaccine is not covered by the VIC program.
Therefore, the success of the patient’s lawsuit hinged entirely on proving that her injury was caused by the pneumococcal vaccine, not the Tdap booster. Without a record of the administration sequence, it was impossible to establish a definitive link. The trial court judge ruled that a jury would be forced to guess at the cause, and the U.S. Court of Appeals for the Fourth Circuit upheld this decision. The court acknowledged the difficult position this placed the patient in but affirmed that the absence of a “causative agent” was a fatal flaw in the case.
The outcome of this lawsuit serves as a powerful reminder for pharmacists. As Dr. Ruble notes, a single sentence documenting the order of vaccinations could have provided the crucial evidence needed to proceed with the case, either in civil court or with the VIC program. The case highlights the complex balance within the legal system and the profound responsibility of pharmacists to maintain detailed and accurate records to protect both their patients and themselves.
